Pledge of $150m to fight neglected diseases

14 10 2010

Six pharmaceutical companies and several governments have pledged more than $150m in medicines and funding over five years to tackle some of the most neglected diseases. The debilitating illnesses — including leprosy, lymphatic filariasis and sleeping sickness — affect 1bn of the world’s poorest people, place a burden on health services, stunt children’s education and hinder economic development. (…) The companies involved are Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Bayer and Eisai of Japan. Image: lidc.org.uk. More…

News selected by Covalence | Country: Global | Company: Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Bayer, Eisai | Source: Financial Times


Actions

Information